Life Scientist > Biotechnology

Biotech and the rise of the patent troll

20 May, 2008 by Kate McDonald

There is a beast stalking the world of intellectual property and biological inventions: the patent troll.


VivaGel well tolerated: Starpharma

12 May, 2008 by Kate McDonald

Starpharma has released positive results from VivaGel clinical trial.


Evado signs distribution deal

14 April, 2008 by Staff Writers

SeerPharma to market new clinical software in Australia and south-east Asia


Slimeballs and eyeballs: hagfish and the evolution of the eye

11 April, 2008 by Kate McDonald

Hagfish may be ferociously ugly little creatures, but they can teach us much about the evolution of the vertebrate eye.


Hedgehog and the need for speed

01 April, 2008 by Fiona Wylie

Model organisms such as zebrafish are vitally important in answering basic questions of developmental cell biology and signalling, and those built for distance and not speed may just have a few more prickles.


Living fossil still calls Australia home

27 March, 2008 by Staff Writers

Fossil bones of the Djarthia, our earliest known marsupial, have been linked to South America's extant Monito del Monte.


Two advance to BIO

26 March, 2008 by Kate McDonald

Two local scientists are off to the BIO convention in June after winning the Advance BioBusiness award.


You say tomato ...

17 March, 2008 by Mauricio Espinoza

US crop scientists discover gene that controls fruit shape.


Big week for Australian biotechs part II

13 March, 2008 by Kate McDonald

Cytopia goes into Phase II trials for vascular disrupting agent while Benitec licensee agrees to develop RNAi-based therapy for hepatitis C.


Big week for Australian biotechs

12 March, 2008 by Kate McDonald

Progen goes into Phase III and ChemGenex Phase II, Bionomics looks at anxiety, Clinuvel gets orphan designation and Avexa announces collaboration and good results.


Bionomics begins Phase 1 trial

27 February, 2008 by Staff Writers

The first patients have begun treatment in Bionomics' Phase 1 trial of its vascular disruption agent.


Good safety results for Prana

26 February, 2008 by Staff Writers

Early results from a 78-patient safety trial are promising for Prana's Alzheimer's compound.


Bats not cats source of SARS

25 February, 2008 by Staff Writers

The evolutionary history of SARS suggests that bats, and not civet cats, were the original source of the virus.


Dragon sex: boys will be girls

22 February, 2008 by Graeme O'Neill

When the heat is on, boys will be girls, at least among bearded dragons.


vivoPharm expands, TGR contracts

06 February, 2008 by Kate McDonald

Adelaide biotechs vivoPharm and TGR expand and contract.


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd